CSIMarket
 
Atara Biotherapeutics Inc   (ATRA)
Other Ticker:  
 
 

Atara Biotherapeutics Inc Balance Sheet Quarterly

ATRA


Select the Financial Report:   Period:   Fiscal Year:




ATRA Balance Sheets
(Quarterly, GAAP in millions $)

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
ASSETS
Cash & cash equivalent 64.79 45.90 48.74 92.94 65.11
Restricted Cash and Cash Equivalents, Current - - - - -
Short-term Investments, Total 37.62 107.74 156.67 149.88 200.29
Cash & Short-term Investments 102.41 153.64 205.41 242.82 265.40
Accounts receivable 0.16 0.51 0.40 40.22 0.25
Other Receivables - - - - -
Notes Receivable, Current - - - - -
Restricted Cash Current 0.15 0.15 0.15 0.15 1.35
Inventories 6.59 7.86 5.34 1.59 -
Other Current Assets 9.53 10.31 13.04 10.45 1.35
Prepaid Expense And Other Assets Current - - - - 16.05
Total Current Assets 118.70 172.32 224.18 295.08 283.05
Equipment/Property/Plant Net 4.63 5.35 5.85 6.30 7.27
Goodwill net - - - - -
Intangible Assets - - - - -
Long-term investments - - - - -
Accounts Receivable, Net, Noncurrent - - - - -
Financial Instruments - - - - -
Tax Assets, Noncurrent - - - - -
Other Assets, Noncurrent 65.46 68.77 72.05 75.00 78.00
Deferred, Prepaid and Other Assets, Noncurrent - - - - -
Disposal Group, Including Discontinued Operation, Assets, Noncurrent AS - - - - -
Total Assets 188.79 246.44 302.08 376.42 368.32
LIABILITIES
Accounts Payable, Current AC 6.51 4.14 5.07 6.87 11.30
Employee-related Liabilities, Current AC 14.43 12.56 8.91 17.66 17.61
Financial Instruments - - - - -
Shortterm Debt - - - - -
Other Liabilities, Current 58.15 57.86 53.90 54.39 43.34
Accrued Income Taxes, Current TA - - - - -
Deferred Liability and Revenue - - - - -
Disposal Group, Including Discontinued Operation, Liabilities, Current LI - - - - -
Accrued Research And Development Expenses Current 23.97 20.74 23.77 24.99 17.87
Operating Lease Liability Noncurrent 48.51 51.75 54.92 58.06 61.07
Total Current Liabilities 79.09 74.55 67.88 78.92 72.24
Long-term debt - - - - -
Capital Lease and Other - - - - -
Long-term Debt Convertible - - - - -
Total Long-term Debt - - - - -
Financial Instruments, Insurance, Noncurrent - - - - -
Employee Benefit Plans, Noncurrent - - - - -
Deferred credits, Noncurrent - - - - -
Accrued Income Taxes, Noncurrent - - - - -
Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent LI - - - - -
Other liabilities, Noncurrent 160.54 164.43 169.25 170.86 108.96
Total Liabilities 239.63 238.99 237.12 249.78 181.20
SHAREHOLDER'S EQUITY
Common Stock Value 0.01 0.01 0.01 0.01 0.01
Additional Paid In Capital Common Stock 1,858.42 1,847.28 1,833.98 1,821.72 1,808.52
Retained Earnings / Accumulated Deficit -1,908.70 -1,838.90 -1,767.80 -1,693.02 -1,618.45
Other Equity -0.57 -0.93 -1.24 -2.07 -2.96
Noncontrolling interests & other - - - - -
Total Stockholder's Equity -50.84 7.45 64.96 126.64 187.11
Liabilities & Stockholder's Equity 188.79 246.44 302.08 376.42 368.32






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com